Yujin Hoshida

UT Southwestern Medical Center

NIH Rank #3520
  • Program Leader
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2.5M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#3,520
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.5M across 4 grants · National rank #3520.

Top grants by award amount

Yujin Hoshida's NIH grant portfolio, ranked by award amount.

  • 5U01CA283935-02U01
    Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules
    $846.6K
    award amount
  • 5R01CA255621-04R01
    Trial of Statins for Chemoprevention in Hepatocellular Carcinoma
    $785.1K
    award amount
  • 5R01CA282178-02R01
    Epigallocatechin gallate for prevention of lethal cirrhosis complications
    $585.6K
    award amount
  • 5U01CA288375-02U01
    Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis
    $323.4K
    award amount

Affiliations

Institutions that have administered grants for Yujin Hoshida.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    UT Southwestern Medical Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3520
  6. 2024
    Entered Top 25% Nationally
    Ranked #3520
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions